男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

China's 10 industries' outlooks for 2024

chinadaily.com.cn | Updated: 2024-01-10 06:40
Share
Share - WeChat
[Photo/IC]

Biotech industry

In 2023, the outbound transaction amount and trading volume of Chinese pharmaceutical companies grew rapidly, and the innovative drugs gradually occupied the dominant position in outbound projects. In 2024, the situation is expected to replicate and continue.

As the industry increased investments in research and development, domestic innovative drugs are expected to enter the quality improvement stage. Moreover, the cost of R&D is likely to stabilize, improving the quality of the R&D projects.

An industry insider said AstraZeneca buying China's Gracell Biotechnologies for $1.2 billion could be a turning point. Gracell will become the first Chinese biotech company to be acquired by a multinational pharmaceutical company.

For many biotech founders and investors, the mergers and acquisitions may become an important exit channel after the A-share IPO stage tightening.

|<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 香港 | 都兰县| 雷州市| 内江市| 罗甸县| 赤水市| 四子王旗| 炉霍县| 襄垣县| 四川省| 黄平县| 闵行区| 大名县| 通山县| 始兴县| 南雄市| 古浪县| 手游| 简阳市| 洪江市| 肃北| 溆浦县| 饶平县| 红桥区| 麻栗坡县| 棋牌| 清涧县| 衡南县| 海城市| 郁南县| 和静县| 黎平县| 壤塘县| 崇仁县| 新沂市| 乌鲁木齐市| 阿克苏市| 松江区| 华池县| 博兴县| 鞍山市|